Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Hepatitis E | Research

Quantification of host proteomic responses to genotype 4 hepatitis E virus replication facilitated by pregnancy serum

Authors: Zhongyao Qian, Chao Cong, Yi Li, Yanhong Bi, Qiuxia He, Tengyuan Li, Yueping Xia, Liangheng Xu, Houfack K. Mickael, Wenhai Yu, Jiankun Liu, Daqiao Wei, Fen Huang

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

Hepatitis E virus (HEV) infection is a common cause of acute hepatitis worldwide and causes approximately 30% case fatality rate among pregnant women. Pregnancy serum (PS), which contains a high concentration of estradiol, facilitates HEV replication in vitro through the suppression of the PI3K–AKT–mTOR and cAMPK–PKA–CREB signaling pathways. However, the proteomics of the complex host responses to HEV infection, especially how PS facilitates viral replication, remains unclear.

Methods

In this study, the differences in the proteomics of HEV-infected HepG2 cells supplemented with fetal bovine serum (FBS) from those of HEV-infected HepG2 cells supplemented with serum from women in their third trimester of pregnancy were quantified by using isobaric tags for relative and absolute quantification technology.

Results

A total of 1511 proteins were identified, among which 548 were defined as differentially expressed proteins (DEPs). HEV-infected cells supplemented with PS exhibited the most significant changes at the protein level. A total of 328 DEPs, including 66 up-regulated and 262 down-regulated proteins, were identified in HEV-infected cells supplemented with FBS, whereas 264 DEPs, including 201 up-regulated and 63 down-regulated proteins, were found in HEV-infected cells supplemented with PS. Subsequently, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses revealed that in HEV-infected cells, PS supplementation adjusted more host genes and signaling pathways than FBS supplementation. The DEPs involved in virus–host interaction participated in complex interactions, especially a large number of immune-related protein emerged in HEV-infected cells supplemented with PS. Three significant or interesting proteins, including filamin-A, thioredoxin, and cytochrome c, in HEV-infected cells were functionally verified.

Conclusions

The results of this study provide new and comprehensive insight for exploring virus–host interactions and will benefit future studies on the pathogenesis of HEV in pregnant women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arankalle VA, Joshi MV, Kulkarni AM, Gandhe SS, Chobe LP, Rautmare SS, et al. Prevalence of anti-hepatitis E virus antibodies in different Indian animal species. J Viral Hepatitis. 2010;8(3):223–7.CrossRef Arankalle VA, Joshi MV, Kulkarni AM, Gandhe SS, Chobe LP, Rautmare SS, et al. Prevalence of anti-hepatitis E virus antibodies in different Indian animal species. J Viral Hepatitis. 2010;8(3):223–7.CrossRef
2.
go back to reference Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res. 2007;127(2):216–28.PubMedCrossRef Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res. 2007;127(2):216–28.PubMedCrossRef
4.
go back to reference Alain KF, Franziska SNA, Phillippe B, Andrea W, Darling KEA, Helen K, et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis. 2011;17(6):1074–8.CrossRef Alain KF, Franziska SNA, Phillippe B, Andrea W, Darling KEA, Helen K, et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis. 2011;17(6):1074–8.CrossRef
5.
go back to reference Tissera G, Lardizabal MC, Torres SB, Fantilli AC, Wassaf MGM, Venezuela F, et al. Hepatitis E virus infection in pregnant women, Argentina. BMC Infect Dis. 2020;20(1):368.PubMedPubMedCentralCrossRef Tissera G, Lardizabal MC, Torres SB, Fantilli AC, Wassaf MGM, Venezuela F, et al. Hepatitis E virus infection in pregnant women, Argentina. BMC Infect Dis. 2020;20(1):368.PubMedPubMedCentralCrossRef
6.
go back to reference Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis e virus infection. Ann Intern Med. 2007;147(1):28–33.PubMedCrossRef Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis e virus infection. Ann Intern Med. 2007;147(1):28–33.PubMedCrossRef
7.
go back to reference Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet. 2004;85(3):240–4.PubMedCrossRef Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet. 2004;85(3):240–4.PubMedCrossRef
8.
go back to reference Li M, Bu Q, Gong W, Li H, Wang L, Li S, et al. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal Neonatal Med. 2020;33(21):3647–51.PubMedCrossRef Li M, Bu Q, Gong W, Li H, Wang L, Li S, et al. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal Neonatal Med. 2020;33(21):3647–51.PubMedCrossRef
9.
go back to reference Ma XX, Ji Y, Jin L, Baloch Z, Zhang DR, Wang Y, et al. Prevalence and clinical features of hepatitis E virus infection in pregnant women: a large cohort study in Inner Mongolia, China. Clin Res Hepatol Gastroenterol. 2021;45(4):101536.PubMedCrossRef Ma XX, Ji Y, Jin L, Baloch Z, Zhang DR, Wang Y, et al. Prevalence and clinical features of hepatitis E virus infection in pregnant women: a large cohort study in Inner Mongolia, China. Clin Res Hepatol Gastroenterol. 2021;45(4):101536.PubMedCrossRef
10.
go back to reference Bi YH, Yang CC, Yu WH, Zhao XC, Zhao CC, He ZL, et al. Pregnancy serum facilitates hepatitis E virus replication in vitro. J Gen Virol. 2015;96:1055–61.PubMedCrossRef Bi YH, Yang CC, Yu WH, Zhao XC, Zhao CC, He ZL, et al. Pregnancy serum facilitates hepatitis E virus replication in vitro. J Gen Virol. 2015;96:1055–61.PubMedCrossRef
11.
go back to reference Gong S, Hao X, Bi Y, Yang C, Wang W, Mickael HK, et al. Hepatitis E viral infection regulates estrogen signaling pathways: Inhibition of the cAMPK-PKA-CREB and PI3K-AKT-mTOR signaling pathways. J Med Virol. 2021;93(6):3769–78.PubMedCrossRef Gong S, Hao X, Bi Y, Yang C, Wang W, Mickael HK, et al. Hepatitis E viral infection regulates estrogen signaling pathways: Inhibition of the cAMPK-PKA-CREB and PI3K-AKT-mTOR signaling pathways. J Med Virol. 2021;93(6):3769–78.PubMedCrossRef
12.
go back to reference Yang C, Yu W, Bi Y, Long F, Li Y, Wei D, et al. Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replication. J Viral Hepat. 2018;25(6):742–51.PubMedCrossRef Yang C, Yu W, Bi Y, Long F, Li Y, Wei D, et al. Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replication. J Viral Hepat. 2018;25(6):742–51.PubMedCrossRef
13.
go back to reference Sooryanarain H, Ahmed SA, Meng XJ. Progesterone-Mediated enhancement of hepatitis E virus replication in human liver cells. MBio. 2021;12(3):e0143421.PubMedCrossRef Sooryanarain H, Ahmed SA, Meng XJ. Progesterone-Mediated enhancement of hepatitis E virus replication in human liver cells. MBio. 2021;12(3):e0143421.PubMedCrossRef
14.
15.
go back to reference Qu CB, Li Y, Li YL, Yu PF, Li PF, Donkers JM, et al. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-kappa B-RIPK1-caspase axis. Antivir Res. 2019;170:104588.PubMedCrossRef Qu CB, Li Y, Li YL, Yu PF, Li PF, Donkers JM, et al. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-kappa B-RIPK1-caspase axis. Antivir Res. 2019;170:104588.PubMedCrossRef
16.
go back to reference Vanderboom PM, Mun DG, Madugundu AK, Mangalaparthi KK, Saraswat M, Garapati K, et al. Proteomic signature of host response to SARS-CoV-2 infection in the nasopharynx. Mol Cell Proteom. 2021;20:100134.CrossRef Vanderboom PM, Mun DG, Madugundu AK, Mangalaparthi KK, Saraswat M, Garapati K, et al. Proteomic signature of host response to SARS-CoV-2 infection in the nasopharynx. Mol Cell Proteom. 2021;20:100134.CrossRef
17.
go back to reference Kan F, Ye L, Yan T, Cao J, Zheng J, Li W. Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model. BMC Genom. 2017;18(1):641.CrossRef Kan F, Ye L, Yan T, Cao J, Zheng J, Li W. Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model. BMC Genom. 2017;18(1):641.CrossRef
18.
go back to reference Berard AR, Coombs KM, Severini A. Quantification of the host response proteome after herpes simplex virus type 1 infection. J Proteome Res. 2015;14(5):2121–42.PubMedCrossRef Berard AR, Coombs KM, Severini A. Quantification of the host response proteome after herpes simplex virus type 1 infection. J Proteome Res. 2015;14(5):2121–42.PubMedCrossRef
19.
go back to reference Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteom. 2004;3(12):1154–69.CrossRef Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteom. 2004;3(12):1154–69.CrossRef
20.
go back to reference Yu W, Ma T, Zhao X, He Z, Yang C, Bi Y, et al. Complete genome sequence of Swine hepatitis e virus prevalent in southwest china. Genome Announc. 2013;2(2):e00090–14. Yu W, Ma T, Zhao X, He Z, Yang C, Bi Y, et al. Complete genome sequence of Swine hepatitis e virus prevalent in southwest china. Genome Announc. 2013;2(2):e00090–14.
21.
go back to reference Huang F, Li Y, Yu W, Jing S, Wang J, Long F, et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis. Hepatology. 2016;64(2):350–9.PubMedCrossRef Huang F, Li Y, Yu W, Jing S, Wang J, Long F, et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis. Hepatology. 2016;64(2):350–9.PubMedCrossRef
22.
go back to reference Cooper J, Liu L, Woodruff EA, Taylor HE, Goodwin JS, D’Aquila RT, et al. Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J Biol Chem. 2011;286(32):28498–510.PubMedPubMedCentralCrossRef Cooper J, Liu L, Woodruff EA, Taylor HE, Goodwin JS, D’Aquila RT, et al. Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J Biol Chem. 2011;286(32):28498–510.PubMedPubMedCentralCrossRef
23.
go back to reference Bi Y, Yang C, Yu W, Zhao X, Zhao C, He Z, et al. Pregnancy serum facilitates hepatitis E virus replication in vitro. J Gen Virol. 2015;96(5):1055–61.PubMedCrossRef Bi Y, Yang C, Yu W, Zhao X, Zhao C, He Z, et al. Pregnancy serum facilitates hepatitis E virus replication in vitro. J Gen Virol. 2015;96(5):1055–61.PubMedCrossRef
24.
go back to reference Gene Ontology C. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049–56. Gene Ontology C. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049–56.
25.
go back to reference Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–62.PubMedCrossRef Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–62.PubMedCrossRef
26.
go back to reference Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52.PubMedCrossRef Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52.PubMedCrossRef
27.
go back to reference Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–32.PubMedCrossRef Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–32.PubMedCrossRef
28.
go back to reference Xu L, Wang WS, Li YL, Zhou XY, Yin YB, Wang YJ, et al. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology. 2017;65(6):1823–39.PubMedCrossRef Xu L, Wang WS, Li YL, Zhou XY, Yin YB, Wang YJ, et al. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology. 2017;65(6):1823–39.PubMedCrossRef
29.
go back to reference Evans C, Noirel J, Ow SY, Salim M, Pereira-Medrano AG, Couto N, et al. An insight into iTRAQ: Where do we stand now? Anal Bioanal Chem. 2012;404(4):1011–27.PubMedCrossRef Evans C, Noirel J, Ow SY, Salim M, Pereira-Medrano AG, Couto N, et al. An insight into iTRAQ: Where do we stand now? Anal Bioanal Chem. 2012;404(4):1011–27.PubMedCrossRef
30.
go back to reference Li Y, Guo T, Wang X, Ni W, Hu R, Cui Y, et al. ITRAQ-based quantitative proteomics reveals the proteome profiles of MDBK cells infected with bovine viral diarrhea virus. Virol J. 2021;18(1):119.PubMedPubMedCentralCrossRef Li Y, Guo T, Wang X, Ni W, Hu R, Cui Y, et al. ITRAQ-based quantitative proteomics reveals the proteome profiles of MDBK cells infected with bovine viral diarrhea virus. Virol J. 2021;18(1):119.PubMedPubMedCentralCrossRef
31.
go back to reference Dapat C, Saito R, Suzuki H, Horigome T. Quantitative phosphoproteomic analysis of host responses in human lung epithelial (A549) cells during influenza virus infection. Virus Res. 2014;179:53–63.PubMedCrossRef Dapat C, Saito R, Suzuki H, Horigome T. Quantitative phosphoproteomic analysis of host responses in human lung epithelial (A549) cells during influenza virus infection. Virus Res. 2014;179:53–63.PubMedCrossRef
32.
go back to reference Zhou XJ, Lai YY, Zhu F. iTRAQ-based quantitative proteomic analysis of haemocyte proteins from crayfish (Procambarus clarkii) infected with white spot syndrome virus (WSSV). J Fish Dis. 2021. Zhou XJ, Lai YY, Zhu F. iTRAQ-based quantitative proteomic analysis of haemocyte proteins from crayfish (Procambarus clarkii) infected with white spot syndrome virus (WSSV). J Fish Dis. 2021.
33.
go back to reference Yuanyi F, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6(11):1034–8.CrossRef Yuanyi F, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6(11):1034–8.CrossRef
34.
go back to reference Ghosh S, Ahrens WA, Phatak SU, Hwang S, Schrum LW, Bonkovsky HL. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes. J Viral Hepat. 2011;18(10):e568–77.PubMedCrossRef Ghosh S, Ahrens WA, Phatak SU, Hwang S, Schrum LW, Bonkovsky HL. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes. J Viral Hepat. 2011;18(10):e568–77.PubMedCrossRef
35.
go back to reference Sonia JB, Concepción GM, Ana R, Lorena MP, Emilia M, Rosa AL, et al. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol. 2016;9(7):838. Sonia JB, Concepción GM, Ana R, Lorena MP, Emilia M, Rosa AL, et al. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol. 2016;9(7):838.
36.
go back to reference Eiji Y, So M, Yoshiyuki M, Zhe C, Hai T, Junji Y. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol. 2013;4(514):514. Eiji Y, So M, Yoshiyuki M, Zhe C, Hai T, Junji Y. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol. 2013;4(514):514.
37.
go back to reference Toru Y, Shin-Ichi O, Hiroshi M, Hajime N, Junji Y. The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid Redox Signal. 2003;5(5):563–70.CrossRef Toru Y, Shin-Ichi O, Hiroshi M, Hajime N, Junji Y. The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid Redox Signal. 2003;5(5):563–70.CrossRef
38.
go back to reference Nakamura H, Tamura SI, Watanabe I, Iwasaki T, Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett. 2002;82(1):165–70.PubMedCrossRef Nakamura H, Tamura SI, Watanabe I, Iwasaki T, Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett. 2002;82(1):165–70.PubMedCrossRef
39.
go back to reference Othumpangat S, Noti JD, Beezhold DH. Lung epithelial cells resist influenza A infection by inducing the expression of cytochrome c oxidase VIc which is modulated by miRNA 4276. Virology. 2014;468–470:256–64.PubMedCrossRef Othumpangat S, Noti JD, Beezhold DH. Lung epithelial cells resist influenza A infection by inducing the expression of cytochrome c oxidase VIc which is modulated by miRNA 4276. Virology. 2014;468–470:256–64.PubMedCrossRef
40.
go back to reference Dan L, Jian D, Zhixin C, Yun C, Na L, Fenglin C, et al. Accurately mapping the location of the binding site for the interaction between hepatitis B virus X protein and cytochrome c oxidase III. Int J Mol Med. 2015;35(2):319–24.CrossRef Dan L, Jian D, Zhixin C, Yun C, Na L, Fenglin C, et al. Accurately mapping the location of the binding site for the interaction between hepatitis B virus X protein and cytochrome c oxidase III. Int J Mol Med. 2015;35(2):319–24.CrossRef
41.
go back to reference Eugenin EA, Berman JW. Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism. J Neurochem. 2013;127(5):644–51.PubMedPubMedCentralCrossRef Eugenin EA, Berman JW. Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism. J Neurochem. 2013;127(5):644–51.PubMedPubMedCentralCrossRef
42.
go back to reference Quan S, Wen Z, Yanjun K, Yan C, Li C, Zhibiao Y, et al. HEV-capsid protein interacts with cytochrome P4502C8 and retinol-binding protein 4. Hepat Mon. 2011;11(11):913–7. Quan S, Wen Z, Yanjun K, Yan C, Li C, Zhibiao Y, et al. HEV-capsid protein interacts with cytochrome P4502C8 and retinol-binding protein 4. Hepat Mon. 2011;11(11):913–7.
43.
go back to reference Moin S, Panteva M, Jameel S. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem. 2007;282(29):21124–33.PubMedCrossRef Moin S, Panteva M, Jameel S. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem. 2007;282(29):21124–33.PubMedCrossRef
45.
go back to reference Dotson D, Woodruff EA, Villalta F, Dong X. Filamin A is involved in HIV-1 Vpu-mediated evasion of host restriction by modulating tetherin expression. J Biol Chem. 2016;291(8):4236–46.PubMedPubMedCentralCrossRef Dotson D, Woodruff EA, Villalta F, Dong X. Filamin A is involved in HIV-1 Vpu-mediated evasion of host restriction by modulating tetherin expression. J Biol Chem. 2016;291(8):4236–46.PubMedPubMedCentralCrossRef
46.
go back to reference Donadon M, Di Tommaso L, Soldani C, Franceschini B, Terrone A, Mimmo A, et al. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy. Liver Int. 2018;38(2):303–11.PubMedCrossRef Donadon M, Di Tommaso L, Soldani C, Franceschini B, Terrone A, Mimmo A, et al. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy. Liver Int. 2018;38(2):303–11.PubMedCrossRef
48.
Metadata
Title
Quantification of host proteomic responses to genotype 4 hepatitis E virus replication facilitated by pregnancy serum
Authors
Zhongyao Qian
Chao Cong
Yi Li
Yanhong Bi
Qiuxia He
Tengyuan Li
Yueping Xia
Liangheng Xu
Houfack K. Mickael
Wenhai Yu
Jiankun Liu
Daqiao Wei
Fen Huang
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Hepatitis E
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02080-5

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.